Summary of "What happens when billions of dollars in research funding goes away"

The Indicator from Planet Money
Host: Darin Woods
Co-Host: Stephen Messaha
Release Date: February 20, 2025

I. Introduction: Birmingham’s Economic Transformation

The episode opens with Darin Woods highlighting the significant economic shift in Birmingham, Alabama. Originally established on the steel industry, Birmingham has reinvented itself as a hub for health research:

Darin Woods (00:14): "There is this building going up in downtown Birmingham, Alabama. And in a way, it's a symbol of how much this city and really the country's entire economy has changed. But because while Birmingham was founded on the steel industry, today it's all about health research."

This transformation underscores the pivotal role that biomedical research plays in modern economies.

II. The Role of NIH Funding in Biomedical Research

Stephen Messaha elaborates on the crucial support provided by federal funding, particularly from the National Institutes of Health (NIH), in fostering the biomedical research industry:

Stephen Messaha (00:32): "Federal funding from the National Institutes of Health has been the rocket behind the biomedical research industry. NIH funds have helped transform not just Birmingham, but other cities like Pittsburgh and Baltimore. It's why the University of Alabama at Birmingham is not only the largest single employer in the city, it's the largest in the entire state."

The substantial NIH funding not only sustains research institutions but also drives local economies by being major employers.

III. The Trump Administration’s Proposed Funding Cuts

The episode delves into the Trump administration's initiative to drastically reduce NIH funding, specifically targeting indirect costs associated with research grants:

Darin Woods (00:52): "And now with the Trump administration trying to make deep cuts to research funding, Birmingham and cities like it are worried about what happens if billions of dollars for the industry disappears overnight."

Stephen Messaha introduces the concept of indirect costs, which are additional expenses beyond the direct costs of research:

Stephen Messaha (03:07): "And the reason this set up all of Geeta's devices is because these cuts would mean Duke losing nearly $200 million in NIH funding."

These cuts aim to address what the administration perceives as excessive spending on overheads by research institutions.

IV. Understanding Direct vs. Indirect Costs

To provide clarity, the hosts break down the difference between direct and indirect costs using an illustrative example:

Stephen Messaha (03:16): "So the Trump administration is targeting a very specific part of NIH funding and giving a specific justification. They're cutting what's sometimes called indirect costs, right?"

Darin Woods (04:27): "And running that lab takes money from the light bulbs to the faucets to that new centrifuge with all the fancy dials. Well, the university wants to get paid for the use of that centrifuge and the tech person running it."

Indirect costs cover essential expenses such as facility maintenance, utilities, and administrative support, which are crucial for sustaining research environments.

V. The Impact of Proposed Cuts on Universities

Geeta Swamy, Associate Vice President for Research at Duke University, shares the immediate repercussions of the proposed funding cuts:

Geeta Swamy (02:41): "So my first reaction was, what are we going to do? How are we going to manage this?"

The administration's directive drastically lowers the indirect cost rate from around 60% negotiated by Duke to a flat 15%:

Darin Woods (04:54): "And the rate Duke negotiated was about 60%. So that $100,000 grant we were talking about actually jumps up to $160,000. And this right here is what the Trump administration says is the problem. They say that is way too much spending on indirect costs."

This reduction threatens to siphon away significant financial resources that universities rely on to maintain their research infrastructure.

VI. Resistance and Legal Challenges

The administration's plan faced immediate backlash from states and universities across the nation, leading to legal interventions:

Darin Woods (07:31): "Sarah says the justification for these cuts are way less important than the simple fact that this represents billions of dollars in promised research funding going away. This is money that these universities relied on and plan. Duke University negotiated its rate with the NIH back in August and that was supposed to last for four to five years."

Nearly half of all states sought judicial relief, resulting in a federal judge freezing the order. This resistance underscores the depth of reliance on NIH funding within academic institutions.

VII. Economic and Research Implications

Sarah Helms McCarty, an economist at Samford University, provides an analysis of the broader economic and research impacts:

Sarah Helms McCarty (08:01): "Treatments for cancer and heart attacks and strokes and Parkinson's, which from an economic perspective, we would argue the government should be helping to subsidize this kind of research. We call this a public good or a positive externality."

The abrupt cuts not only threaten vital research but also jeopardize economic stability in communities dependent on research funding:

Darin Woods (08:23): "You know, this funding is also sort of a form of economic development for these areas. Literally hundreds of millions of dollars flowing into states like North Carolina and Alabama. Cutting this funding also means extracting these dollars out of communities that have come to rely on them."

VIII. Job Security and Institutional Stability

The proposed cuts have direct consequences on employment and institutional operations:

Sarah Helms McCarty (08:52): "You know, anecdotally I have friends who work in the labs at UAB and they're very concerned. I was texting with them last week, like, hey, you know. And they're like, yeah, I'm dusting off my resume because I don't know what this means for me."

Duke University anticipates thousands of job losses, and institutions like North Carolina State University have already implemented hiring freezes in response.

IX. Perspectives from Private Foundations

Contrasting NIH funding, private grant providers like the Bill and Melinda Gates Foundation adopt a different approach to indirect costs:

Darin Woods (06:09): "Sarah says part of that is because groups like the Gates foundation offer more flexibility for spending. And she adds, the type of research private groups are doing tends to be a lot less lab intensive."

The Gates Foundation caps indirect costs at around 10%, reflecting their focus on less overhead-heavy projects that facilitate broader application rather than intensive laboratory research.

X. Broader Political and Economic Context

Despite the administration's assertion that the cuts are a step towards more efficient funding allocation, the economic significance of the proposed reductions remains contentious:

Stephen Messaha (09:40): "We reached out to the NIH. It redirected us to Health and Human Services. So we asked HHS if the funds saved from cutting the indirect costs would go back into direct research. We also asked if they could respond to criticisms that the abruptness of these attempted cuts are threatening life-saving work. The HHS did not respond to our emails or a couriered letter detailing these questions."

This lack of transparency and communication exacerbates concerns about the long-term viability of biomedical research funding under the new administration.

XI. Conclusion: The Future of Biomedical Research Funding

The episode concludes by reflecting on the delicate balance between managing federal budgets and sustaining essential research. While the administration posits that reducing indirect costs will channel more funds directly into research, the immediate and potential long-term impacts on institutions, economies, and life-saving research present significant challenges. The resistance from universities and states indicates that any such sweeping changes require careful consideration of the multifaceted roles that research funding plays in both scientific advancement and economic stability.

Notable Quotes with Timestamps:

• Darin Woods (00:14): "There is this building going up in downtown Birmingham, Alabama. And in a way, it's a symbol of how much this city and really the country's entire economy has changed... today it's all about health research."

• Stephen Messaha (00:32): "Federal funding from the National Institutes of Health has been the rocket behind the biomedical research industry."

• Geeta Swamy (02:41): "So my first reaction was, what are we going to do? How are we going to manage this?"

• Sarah Helms McCarty (08:01): "Treatments for cancer and heart attacks and strokes and Parkinson's... we call this a public good or a positive externality."

• Sarah Helms McCarty (08:52): "I'm dusting off my resume because I don't know what this means for me."

This comprehensive summary encapsulates the critical discussions and insights from the episode, providing a clear understanding of the implications surrounding the proposed NIH funding cuts without needing to listen to the original podcast.